Bontril Sr Oral Capsule, Extended Release 105Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Bontril SR: Oral capsule, extended release (105mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5354.JPG
Melfiat 105 Unicelles ER Cap
Eon Labs Inc a Division of Sandoz
Pill Identification: NUMARK 1082 
Drug Image file DrugItem_1440.JPG
Melfiat 105 Unicelles ER Cap
Numark Laboratories Inc
Pill Identification: NUMARK 1082 
Drug Image file DrugItem_3436.JPG
Bontril 105mg Slow-Release Cap
Amarin Pharmaceuticals Inc
Pill Identification: A 047 
Drug Image file DrugItem_8438.JPG
Bontril 105mg Slow-Release Cap
Valeant Pharmaceuticals
Pill Identification: VALEANT BONTRIL 105 
Drug Image file DrugItem_10304.JPG
Bontril 105mg Slow-Release Cap
PD-RX Pharmaceuticals
Pill Identification: VALEANT BONTRIL 105 
Drug Image file DrugItem_12439.JPG
Phendimetrazine 105mg ER Cap
PD-RX Pharmaceuticals
Pill Identification: E5254 E5254 
Drug Image file DrugItem_781.JPG
Bontril 105mg Slow-Release Cap
Carnrick Laboratories Inc Div GW Carnrick Co
Pill Identification: A 047 
Drug Image file DrugItem_5466.JPG
Phendimetrazine 105mg ER Cap
Eon Labs Inc a Division of Sandoz
Pill Identification: E5254 E5254 

What is this Medicine?

PHENDIMETRAZINE (fen dye MET ra zeen) decreases your appetite. It is used with a reduced calorie diet and exercise to help you lose weight.

In-Depth Information
Select a Medication

Bontril 105mg Slow-Release Capsule (OM)

NDC: 652340047
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Obesity

Bontril 105mg Slow-Release Capsule (OM)
Drug Image file DrugItem_3436.JPG
Amarin Pharmaceuticals Inc
Pill Identification: A 047 
Shape: capsule
Color: green,yellow

Reported Side Effects for Bontril 105mg Slow-Release Capsule (OM)

Eye Irritation Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Elated Mood Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Dysphoria Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Dyskinesia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Stiff Heart Vavle Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Psychosis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Fluid Retention Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
High Pressure In Lungs Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
Rapid Heart Rate Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Large Pupil Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Increased Sexual Desire Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Decreased Sexual Desire Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Irritability Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Increased Urination Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Painful Urination Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Excessive Sweating Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Dry Mouth Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Restlessness Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Tolerance Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Bontril 105mg Slow-Release Capsule (OM)

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Bontril 105mg Slow-Release Capsule (OM)(Phendimetrazine Tartrate)
Alcohol and Phendimetrazine Tartrate(Phendimetrazine Tartrate)
Side effects from Phendimetrazine such as dizziness, lightheadedness, fainting, or confusion may get worse if you consume alcohol-containing products.
Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Bontril 105mg Slow-Release Capsule (OM)(Phendimetrazine Tartrate)
Caffeine-containing Foods/Beverages and Phendimetrazine Tartrate(Phendimetrazine Tartrate)
Limit caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Phendimetrazine. Also avoid medicines containing additional Caffeine whenever possible. Side effects from Phendimetrazine may get worse if you take excessive Caffeine. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, tremor, or other side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More